Read time: 4 minutes. Though many of us would like to deny it, our neighbors affect us. Their loud music disturbs our sleep. The scent of their dinner wafts through an open window
Read time: 3 minutes. The 2026 Targeted Therapies of Lung Cancer Meeting brought together leading clinicians, researchers, and patient advocates to discuss the latest advances
Read time: 3 minutes. Every January, the American Cancer Society releases a Cancer Facts & Figures report. It provides a clear view of where we stand in addressing cancer. The 2026
Read time: 3 minutes. Research funders are increasingly calling on researchers to move beyond studying communities to actively involving them in the research process. They want
Read time: 2 minutes. Artificial intelligence (AI) is rapidly reshaping the future of cancer care, but such dramatic innovation also brings important questions. AI has evolved from
Read time: 3 minutes. The human immune system is an intricate web of checks and balances that usually excels at detecting and destroying foreign invaders, such as bacteria and
Read time: 2 minutes. The Society for Immunotherapy of Cancer (SITC) celebrated their 40 th anniversary at their annual meeting in National Harbor, Maryland from November 5-9, 2025
LUNGevity partnered with MD Anderson, UT Southwestern, and UT San Antonio to host panel discussions sharing valuable insights and helpful resources for people living with lung
Read time: 1 minute. For more than two decades, LUNGevity Foundation has been a leader in advancing lung cancer research. Since 2002, we have invested $55+ million in more than 200
Read time: 2 minutes. Comprehensive biomarker testing is one of the most powerful tools in modern lung cancer care, guiding treatment decisions and improving patient outcomes. Yet
Read time: 2 minutes. Over the past twenty years, lung cancer research and care have entered a new era. One filled with hope, innovation, and progress that is transforming what it
Read time: 3 minutes. Timely comprehensive biomarker testing has become the cornerstone of precision medicine in lung cancer care. For people diagnosed with non–small cell lung